The brain tissue response to surgical injury and its possible contribution to glioma recurrence Lauriane HamardDavid RatelDidier Wion Topic Review 09 March 2016 Pages: 1 - 8
Pro-apoptotic and anti-angiogenic properties of the α /β-thujone fraction from Thuja occidentalis on glioblastoma cells Angelo TorresYosselyn VargasClaudia Quezada Laboratory Investigation 22 February 2016 Pages: 9 - 19
Cationizable lipid micelles as vehicles for intraarterial glioma treatment Juliane NguyenJohann R. N. CookeShailendra Joshi Laboratory Investigation 22 February 2016 Pages: 21 - 28
Combined inhibition of vascular endothelial growth factor receptor signaling with temozolomide enhances cytotoxicity against human glioblastoma cells via downregulation of Neuropilin-1 Jungwhoi LeeEunsoo KimKyungsun Choi Laboratory Investigation 07 March 2016 Pages: 29 - 34
MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway Li HongLiu Ya-weiLu Yun-tao Laboratory Investigation 12 March 2016 Pages: 35 - 45
Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma Holly LindsayYulun HuangXiao-Nan Li Laboratory Investigation 08 March 2016 Pages: 47 - 56
Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids Eduard H. PanosyanJoseph L. LaskyP. Leia Nghiemphu Clinical Study 27 February 2016 Pages: 57 - 66
Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma Cecelia Elizabeth GzellHelen R. WheelerMichael Back Clinical Study 15 February 2016 Pages: 67 - 74
Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study Carlos Kamiya-MatsuokaAsif M. PakerMonica E. Loghin Clinical Study 22 February 2016 Pages: 75 - 84
Recurrent glioblastoma: who receives tumor specific treatment and how often? Rieke SteffensSabine SemrauRainer Fietkau Clinical Study 23 February 2016 Pages: 85 - 92
Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases Yingmei LiWenying PanMelanie Hayden Gephart Clinical Study 09 March 2016 Pages: 93 - 100
Vestibular schwannoma and pituitary adenoma in the same patient: coincidence or novel clinical association? Matthew L. CarlsonNeil S. PatelMichael J. Link Clinical Study 22 February 2016 Pages: 101 - 108
Neuro-oncology family caregivers are at risk for systemic inflammation Paula R. SherwoodThomas J. PriceAnna L. Marsland Clinical Study 23 February 2016 Pages: 109 - 118
Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries Deborah C. MarshallLogan P. MarcusClark C. Chen Clinical Study 07 March 2016 Pages: 119 - 128
Clinical features of subarachnoid hemorrhage in patients with positive cancer history Ichiyo ShibaharaTakashi WatanabeTeiji Tominaga Clinical Study 20 February 2016 Pages: 129 - 136
Pencil beam scanning proton therapy for pediatric intracranial ependymoma Carmen AresFrancesca AlbertiniDamien C. Weber Clinical Study 05 March 2016 Pages: 137 - 145
Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma J. DuerinckS. Du FourB. Neyns Clinical Study 02 March 2016 Pages: 147 - 155
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study Enrico FranceschiRoberta DepenniThe PERNO Study Group Clinical Study 04 March 2016 Pages: 157 - 162
Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial Mustafa KhasrawAdrian LeeHelen Wheeler Clinical Study 02 March 2016 Pages: 163 - 171
Comment on: the role of biopsy in the management of patients with presumed diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline Christoph SchwartzFriedrich-Wilhelm Kreth Letter to the Editor 26 February 2016 Pages: 173 - 173
Neuro-oncology biotech industry progress report Shamik ChakrabortyImithri BodhinayakeJohn A. Boockvar Meeting Proceedings 20 February 2016 Pages: 175 - 182
Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment Dimitrios MathiosJacob RuzevickMichael Lim Erratum 09 May 2016 Pages: 183 - 183